Alerts will be sent to your verified email
Verify Email
VIMTALABS
|
Vimta Labs
|
Krsnaa Diagnostics
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.67 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
12.51 % | 8.55 % | 4.89 % |
|
5yr average Equity Multiplier
|
1.33 | 1.35 | 1.8 |
|
5yr Average Asset Turnover Ratio
|
0.82 | 0.54 | 0.32 |
|
5yr Avg Net Profit Margin
|
11.37 % | 11.94 % | 5.91 % |
|
Price to Book
|
7.18 | 2.63 | 0.38 |
|
P/E
|
36.66 | 28.72 | 13.32 |
|
5yr Avg Cash Conversion Cycle
|
122.88 Days | -61.33 Days | -378.19 Days |
|
Inventory Days
|
26.64 Days | 13.68 Days | 3.89 Days |
|
Days Receivable
|
95.75 Days | 115.54 Days | 13.34 Days |
|
Days Payable
|
309.83 Days | 297.83 Days | 205.76 Days |
|
5yr Average Interest Coverage Ratio
|
21.55 | 6.88 | 2.0 |
|
5yr Avg ROCE
|
16.46 % | 11.9 % | 11.91 % |
|
5yr Avg Operating Profit Margin
|
25.53 % | 25.94 % | 30.14 % |
|
5 yr average Debt to Equity
|
0.11 | 0.13 | 0.73 |
|
5yr CAGR Net Profit
|
43.08 % | 2.56 % | -2.95 % |
|
5yr Average Return on Assets
|
9.62 % | 6.39 % | 2.0 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.99 % | 27.11 % | 57.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.47 % | -0.69 % | -14.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.48 % | -0.53 % | 0.0 |
|
Vimta Labs
|
Krsnaa Diagnostics
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|